396 related articles for article (PubMed ID: 24561613)
1. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.
Ehling J; Bartneck M; Wei X; Gremse F; Fech V; Möckel D; Baeck C; Hittatiya K; Eulberg D; Luedde T; Kiessling F; Trautwein C; Lammers T; Tacke F
Gut; 2014 Dec; 63(12):1960-1971. PubMed ID: 24561613
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
[TBL] [Abstract][Full Text] [Related]
4. The CCR2
Bartneck M; Schrammen PL; Möckel D; Govaere O; Liepelt A; Krenkel O; Ergen C; McCain MV; Eulberg D; Luedde T; Trautwein C; Kiessling F; Reeves H; Lammers T; Tacke F
Cell Mol Gastroenterol Hepatol; 2019; 7(2):371-390. PubMed ID: 30704985
[TBL] [Abstract][Full Text] [Related]
5. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.
Heymann F; Hammerich L; Storch D; Bartneck M; Huss S; Rüsseler V; Gassler N; Lira SA; Luedde T; Trautwein C; Tacke F
Hepatology; 2012 Mar; 55(3):898-909. PubMed ID: 22031018
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor promotes fibrosis resolution and repair in mice.
Yang L; Kwon J; Popov Y; Gajdos GB; Ordog T; Brekken RA; Mukhopadhyay D; Schuppan D; Bi Y; Simonetto D; Shah VH
Gastroenterology; 2014 May; 146(5):1339-50.e1. PubMed ID: 24503129
[TBL] [Abstract][Full Text] [Related]
7. The Spleen Promotes the Secretion of CCL2 and Supports an M1 Dominant Phenotype in Hepatic Macrophages During Liver Fibrosis.
Li L; Wei W; Li Z; Chen H; Li Y; Jiang W; Chen W; Kong G; Yang J; Li Z
Cell Physiol Biochem; 2018; 51(2):557-574. PubMed ID: 30458454
[TBL] [Abstract][Full Text] [Related]
8. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Liu CH; Chan KM; Chiang T; Liu JY; Chern GG; Hsu FF; Wu YH; Liu YC; Chen Y
Mol Pharm; 2016 Jul; 13(7):2253-62. PubMed ID: 27224003
[TBL] [Abstract][Full Text] [Related]
9. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
10. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
[TBL] [Abstract][Full Text] [Related]
11. CCL2: a link between hepatic inflammation, fibrosis and angiogenesis?
Affò S; Sancho-Bru P
Gut; 2014 Dec; 63(12):1834-5. PubMed ID: 24694577
[No Abstract] [Full Text] [Related]
12. Curcumin protects against liver fibrosis by attenuating infiltration of Gr1hi monocytes through inhibition of monocyte chemoattractant protein-1.
Huang R; Liu Y; Xiong Y; Wu H; Wang G; Sun Z; Chen J; Yan X; Pan Z; Xia J; Zhang Z; Wang J; Wu C
Discov Med; 2016 Jun; 21(118):447-57. PubMed ID: 27448781
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
14. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.
Cho HR; Kumari N; Thi Vu H; Kim H; Park CK; Choi SH
Sci Rep; 2019 Jul; 9(1):11085. PubMed ID: 31366997
[TBL] [Abstract][Full Text] [Related]
15. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
[TBL] [Abstract][Full Text] [Related]
16. Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.
Ninichuk V; Clauss S; Kulkarni O; Schmid H; Segerer S; Radomska E; Eulberg D; Buchner K; Selve N; Klussmann S; Anders HJ
Am J Pathol; 2008 Mar; 172(3):628-37. PubMed ID: 18258851
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
[TBL] [Abstract][Full Text] [Related]
18. Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling.
Gao J; Wei B; Liu M; Hirsova P; Sehrawat TS; Cao S; Hu X; Xue F; Yaqoob U; Kang N; Cui H; Pomerantz WCK; Kostallari E; Shah VH
Hepatology; 2021 Jun; 73(6):2468-2483. PubMed ID: 33159815
[TBL] [Abstract][Full Text] [Related]
19. Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
Calderone V; Gallego J; Fernandez-Miranda G; Garcia-Pras E; Maillo C; Berzigotti A; Mejias M; Bava FA; Angulo-Urarte A; Graupera M; Navarro P; Bosch J; Fernandez M; Mendez R
Gastroenterology; 2016 Apr; 150(4):982-97.e30. PubMed ID: 26627607
[TBL] [Abstract][Full Text] [Related]
20. Macrophage heterogeneity in liver injury and fibrosis.
Tacke F; Zimmermann HW
J Hepatol; 2014 May; 60(5):1090-6. PubMed ID: 24412603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]